2Singal PK, Khaper N, Farahmand F, et al. Oxidative stress in congestive heart failure[J]. Curr Cardiol Rep, 2000, 2:206-211.
3Ruffolo RR Jr, Feuerstein GZ. Neurohormonal action, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart frilure[J]. J Cardiovasc Pharmacol, 1998,32(suppl):S22-30.
4Tsutsui H, Ide T, HayashidsniS, et al. Greater susceptibility of failing cardiac myocytes to oxygen free radical-mediated injury[J]. Cardiovasc Res, 2001, 49:103-109.
5Lopaschuk GD. Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism[J]. Presse Med, 1998, 27:2001-2004.
6EMIP-FR Pilot Study Group. Free radicals, reperfusion and myocardial infarction therapy: European Myocardial Infarction Project-free radicals pilot study[J]. Eur Heart J, 1993,14(Suppl G):48-51.
7Hisatome I, Ishiko R, Tanka Y, et al. Trimetazidine inhibits Na+,K+-ATPase activity and overdrive hyperpolarization in guinea-pig ventricular muscles. Eur J Pharmacol, 1991,195:381-388.
8Reymond F, Steyaert G, Carrupt PA, et al. The PH-partition profile of the anti-ischemic drug trimetazidine may explain its reduction of intracellular acidosis[J]. Pharm Res, 1999, 16:616-624.
9C. Monpère,M. Brochier,J. Demange,G. Ducloux,J.F. Warin. Combination of trimetazidine with nifedipine in effort angina[J] 1990,Cardiovascular Drugs and Therapy(4):824～825
10Sergio Dalla-Volta,Giuseppe Maraglino,Patricia Della-Valentina,Pietro Viena,Alessandro Desideri. Comparison of trimetazidine with nifedipine in effort angina: A double-blind, crossover study[J] 1990,Cardiovascular Drugs and Therapy(4):853～859
